XPH vs. FPHAX
Compare and contrast key facts about SPDR S&P Pharmaceuticals ETF (XPH) and Fidelity Select Pharmaceuticals Portfolio (FPHAX).
XPH is a passively managed fund by State Street that tracks the performance of the S&P Pharmaceuticals Select Industry Index. It was launched on Jun 19, 2006. FPHAX is managed by Fidelity. It was launched on Jun 17, 2001.
Performance
XPH vs. FPHAX - Performance Comparison
Loading graphics...
XPH vs. FPHAX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XPH SPDR S&P Pharmaceuticals ETF | -3.32% | 31.60% | 4.94% | 2.97% | -9.83% | -10.54% | 14.68% | 25.61% | -15.32% | 12.05% |
FPHAX Fidelity Select Pharmaceuticals Portfolio | -2.56% | 30.41% | 9.39% | 12.54% | 0.94% | 11.79% | 11.16% | 31.73% | 5.41% | 10.70% |
Returns By Period
In the year-to-date period, XPH achieves a -3.32% return, which is significantly lower than FPHAX's -2.56% return. Over the past 10 years, XPH has underperformed FPHAX with an annualized return of 3.82%, while FPHAX has yielded a comparatively higher 10.94% annualized return.
XPH
- 1D
- 5.32%
- 1M
- -5.56%
- YTD
- -3.32%
- 6M
- 13.19%
- 1Y
- 24.45%
- 3Y*
- 11.04%
- 5Y*
- 2.79%
- 10Y*
- 3.82%
FPHAX
- 1D
- 0.57%
- 1M
- -9.52%
- YTD
- -2.56%
- 6M
- 15.21%
- 1Y
- 27.23%
- 3Y*
- 16.20%
- 5Y*
- 11.88%
- 10Y*
- 10.94%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
XPH vs. FPHAX - Expense Ratio Comparison
XPH has a 0.35% expense ratio, which is lower than FPHAX's 0.75% expense ratio.
Return for Risk
XPH vs. FPHAX — Risk / Return Rank
XPH
FPHAX
XPH vs. FPHAX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Pharmaceuticals ETF (XPH) and Fidelity Select Pharmaceuticals Portfolio (FPHAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XPH | FPHAX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.00 | 1.14 | -0.13 |
Sortino ratioReturn per unit of downside risk | 1.47 | 1.61 | -0.14 |
Omega ratioGain probability vs. loss probability | 1.19 | 1.21 | -0.02 |
Calmar ratioReturn relative to maximum drawdown | 1.77 | 2.05 | -0.29 |
Martin ratioReturn relative to average drawdown | 5.52 | 5.99 | -0.47 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| XPH | FPHAX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.00 | 1.14 | -0.13 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.14 | 0.67 | -0.54 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.17 | 0.62 | -0.45 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.38 | 0.52 | -0.14 |
Correlation
The correlation between XPH and FPHAX is 0.81, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
XPH vs. FPHAX - Dividend Comparison
XPH's dividend yield for the trailing twelve months is around 0.69%, less than FPHAX's 5.83% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
XPH SPDR S&P Pharmaceuticals ETF | 0.69% | 0.83% | 1.58% | 1.28% | 1.64% | 0.95% | 0.47% | 0.64% | 0.65% | 0.67% | 0.63% | 7.15% |
FPHAX Fidelity Select Pharmaceuticals Portfolio | 5.83% | 5.68% | 1.90% | 8.08% | 5.18% | 11.09% | 8.85% | 8.33% | 1.65% | 1.62% | 1.07% | 12.63% |
Drawdowns
XPH vs. FPHAX - Drawdown Comparison
The maximum XPH drawdown since its inception was -48.03%, which is greater than FPHAX's maximum drawdown of -38.26%. Use the drawdown chart below to compare losses from any high point for XPH and FPHAX.
Loading graphics...
Drawdown Indicators
| XPH | FPHAX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.03% | -38.26% | -9.77% |
Max Drawdown (1Y)Largest decline over 1 year | -13.15% | -11.00% | -2.15% |
Max Drawdown (5Y)Largest decline over 5 years | -31.63% | -28.82% | -2.81% |
Max Drawdown (10Y)Largest decline over 10 years | -35.97% | -28.82% | -7.15% |
Current DrawdownCurrent decline from peak | -7.29% | -9.82% | +2.53% |
Average DrawdownAverage peak-to-trough decline | -17.37% | -9.21% | -8.16% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.23% | 4.35% | +0.88% |
Volatility
XPH vs. FPHAX - Volatility Comparison
SPDR S&P Pharmaceuticals ETF (XPH) has a higher volatility of 9.49% compared to Fidelity Select Pharmaceuticals Portfolio (FPHAX) at 6.10%. This indicates that XPH's price experiences larger fluctuations and is considered to be riskier than FPHAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| XPH | FPHAX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.49% | 6.10% | +3.39% |
Volatility (6M)Calculated over the trailing 6-month period | 16.38% | 14.17% | +2.21% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.72% | 23.39% | +1.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.56% | 17.69% | +2.87% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.22% | 17.78% | +4.44% |